Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neonatology

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    October 2021
  1. SATRELL E, Clemm H, Roksund O, Hufthammer KO, et al
    Development of lung diffusion to adulthood following extremely preterm birth.
    Eur Respir J. 2021 Oct 8. pii: 13993003.04103-2020.
    PubMed     Abstract available


    September 2021
  2. HART K, Cousins M, Watkins WJ, Kotecha SJ, et al
    Association of Early Life Factors with Prematurity-Associated Lung Disease: Prospective Cohort Study.
    Eur Respir J. 2021 Sep 29. pii: 13993003.01766-2021.
    PubMed     Abstract available


  3. MARTIN C, Burgel PR
    Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries.
    Eur Respir J. 2021;58.
    PubMed    


  4. MCKONE EF, Ariti C, Jackson A, Zolin A, et al
    Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    August 2021
  5. ANTIGNY F, Le Ribeuz H, Humbert M, Montani D, et al
    Comment on: Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.
    Eur Respir J. 2021;58.
    PubMed    


  6. FILIPOW N, Davies G, Main E, Sebire NJ, et al
    Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    July 2021
  7. DELACOURT C, Bertille N, Salomon LJ, Rashenas M, et al
    Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations.
    Eur Respir J. 2021 Jul 15. pii: 13993003.00949-2021.
    PubMed     Abstract available


  8. MESSIKA J, Bunel V, Weisenburger G, Godet C, et al
    Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg?
    Eur Respir J. 2021;58.
    PubMed    


  9. STAHL M
    Sensitive markers to detect progression of lung disease in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    PubMed    


  10. STANOJEVIC S, Davis SD, Perrem L, Shaw M, et al
    Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  11. FRAUCHIGER BS, Binggeli S, Yammine S, Spycher B, et al
    Longitudinal course of clinical lung clearance index in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    June 2021
  12. VANHAVERBEKE K, Slaats M, Al-Nejar M, Everaars N, et al
    Functional respiratory imaging provides novel insights into the long-term respiratory sequelae of bronchopulmonary dysplasia.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  13. HAGNER M, Albrecht M, Guerra M, Braubach P, et al
    IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  14. LASELVA O, Bartlett C, Gunawardena TNA, Ouyang H, et al
    Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  15. GILLAN JL, Davidson DJ, Gray RD
    Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    May 2021
  16. STEWART S, Chan YK, Playford D, Strange GA, et al
    Mild pulmonary hypertension and premature mortality among 154 956 men and women undergoing routine echocardiography.
    Eur Respir J. 2021 May 28. pii: 13993003.00832-2021.
    PubMed     Abstract available


  17. HUGHES DA, Bokobza I, Carr SB
    Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis.
    Eur Respir J. 2021;57.
    PubMed    


    April 2021
  18. COSIN-TOMAS M, Bustamante M, Sunyer J
    Epigenetic association studies at birth and the origin of lung function development.
    Eur Respir J. 2021;57.
    PubMed    


  19. MUNIDASA S, Couch MJ, Rayment JH, Voskrebenzev A, et al
    Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis.
    Eur Respir J. 2021;57.
    PubMed    


  20. DECLERCQ M, de Zeeuw P, Conchinha NV, Geldhof V, et al
    Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  21. BARTELL JA, Sommer LM, Marvig RL, Skov M, et al
    Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  22. AGUSTI A, Breyer-Kohansal R, Faner R
    Transitioning from infancy to adulthood: a black box full of opportunities.
    Eur Respir J. 2021;57.
    PubMed    


    February 2021
  23. O'SHEA KM, O'Carroll OM, Carroll C, Grogan B, et al
    Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease.
    Eur Respir J. 2021;57.
    PubMed    


    January 2021
  24. HARDISTY GR, Law SM, Carter S, Grogan B, et al
    Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations.
    Eur Respir J. 2021;57.
    PubMed    


  25. RAMALHO AS, Furstova E, Vonk AM, Ferrante M, et al
    Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  26. BENGTSON CD, Kim MD, Anabtawi A, He J, et al
    Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    November 2020
  27. MUKHERJEE N, Arathimos R, Chen S, Kheirkhah Rahimabad P, et al
    DNA methylation at birth is associated with lung function development till age 26 years.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03505-2020.
    PubMed     Abstract available


    September 2020
  28. MARTIN C, Burgel PR
    Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?
    Eur Respir J. 2020;56.
    PubMed    


    May 2020
  29. ERICSSON AC
    Bronchopulmonary dysplasia: a crime of opportunity?
    Eur Respir J. 2020;55.
    PubMed    


  30. RANG C, Keating D, Wilson J, Kotsimbos T, et al
    Re-imagining cystic fibrosis care: next generation thinking.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  31. TURKOVIC L, Caudri D, Rosenow T, Breuer O, et al
    Structural determinants of long-term functional outcomes in young children with cystic fibrosis.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


    April 2020
  32. POLLAK M, Shaw M, Wilson D, Grasemann H, et al
    Bronchodilator Responsiveness in Children with Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis.
    Eur Respir J. 2020 Apr 8. pii: 13993003.00175-2020.
    PubMed    


  33. KENTGENS AC, Oppelaar M, Merkus P
    A new breeze from an inspiring past: normality with multiple breath washout in school-aged children.
    Eur Respir J. 2020;55.
    PubMed    


  34. FLUME PA, VanDevanter DR
    Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes.
    Eur Respir J. 2020;55.
    PubMed    


    November 2018
  35. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Neonatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: